Kareem L. Graham

798 total citations
18 papers, 633 citations indexed

About

Kareem L. Graham is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Kareem L. Graham has authored 18 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Kareem L. Graham's work include T-cell and B-cell Immunology (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kareem L. Graham is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kareem L. Graham collaborates with scholars based in United States, Australia and India. Kareem L. Graham's co-authors include Paul J. Utz, Lowen Y. Lee, Peggy P. Ho, Raymond A. Sobel, Eugene C. Butcher, Lawrence Steinman, Imelda Balboni, Brian A. Zabel, Maria Zoudilova and Paul J. Hertzog and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Kareem L. Graham

18 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kareem L. Graham United States 14 358 198 179 87 78 18 633
Susana Brun France 11 251 0.7× 154 0.8× 69 0.4× 87 1.0× 115 1.5× 21 609
Robert Hanczko United States 5 358 1.0× 291 1.5× 263 1.5× 87 1.0× 71 0.9× 5 763
Yoko Okunuki Japan 22 354 1.0× 312 1.6× 145 0.8× 78 0.9× 81 1.0× 47 1.3k
Edward Doherty United States 8 464 1.3× 285 1.4× 282 1.6× 88 1.0× 73 0.9× 12 816
Meng-Yun Chou United States 7 540 1.5× 221 1.1× 109 0.6× 28 0.3× 152 1.9× 7 923
Maha Dawood United States 5 525 1.5× 253 1.3× 382 2.1× 110 1.3× 73 0.9× 7 887
Xiaomin Lin China 14 189 0.5× 151 0.8× 259 1.4× 27 0.3× 87 1.1× 30 686
Tatjana Samardžić Czechia 15 329 0.9× 148 0.7× 40 0.2× 87 1.0× 33 0.4× 24 624
Prasad Srikakulapu United States 14 562 1.6× 180 0.9× 89 0.5× 55 0.6× 223 2.9× 18 825
Anwesha Laha United States 9 278 0.8× 230 1.2× 54 0.3× 67 0.8× 64 0.8× 14 585

Countries citing papers authored by Kareem L. Graham

Since Specialization
Citations

This map shows the geographic impact of Kareem L. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kareem L. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kareem L. Graham more than expected).

Fields of papers citing papers by Kareem L. Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kareem L. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kareem L. Graham. The network helps show where Kareem L. Graham may publish in the future.

Co-authorship network of co-authors of Kareem L. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Kareem L. Graham. A scholar is included among the top collaborators of Kareem L. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kareem L. Graham. Kareem L. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Graham, Kareem L., Charles R. Krois, Melissa LaJevic, et al.. (2019). DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences. 116(8). 3126–3135. 17 indexed citations
2.
Kiefel, Helena, Yuliya V. Katlinskaya, Sunit Jain, et al.. (2019). Abstract 1490: Novel microbiome-derived peptides activate the host innate immune system by regulation of TLR signaling. Cancer Research. 79(13_Supplement). 1490–1490. 1 indexed citations
3.
Lee, Jae‐Kyung, George T. Kannarkat, Jaegwon Chung, et al.. (2016). RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 13(1). 24–24. 21 indexed citations
4.
Quirós, Miguel, Giovanna Leoni, Rachit Agarwal, et al.. (2016). The Specialized Pro‐resolving Lipid Mediator Resolvin E1 Promotes Intestinal Mucosal Wound Repair. The FASEB Journal. 30(S1). 1 indexed citations
5.
Graham, Kareem L., Jian V. Zhang, Susanna Lewén, et al.. (2014). A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease. PLoS ONE. 9(12). e112925–e112925. 56 indexed citations
6.
Han, May, Deborah H. Lundgren, Siddhartha Jaiswal, et al.. (2012). Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. The Journal of Experimental Medicine. 209(7). 1325–1334. 123 indexed citations
7.
Graham, Kareem L., Brian A. Zabel, Sanam Loghavi, et al.. (2009). Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease. The Journal of Immunology. 183(10). 6717–6723. 72 indexed citations
8.
Graham, Kareem L., Lowen Y. Lee, Julian P. T. Higgins, et al.. (2009). Treatment with a Toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity. 43(2). 140–155. 25 indexed citations
9.
Graham, Kareem L., et al.. (2009). Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Research & Therapy. 11(4). R112–R112. 68 indexed citations
10.
Chu, Alvina D., Kareem L. Graham, Imelda Balboni, et al.. (2008). IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. Journal of Clinical Investigation. 118(4). 1417–1426. 75 indexed citations
11.
Graham, Kareem L., Lowen Y. Lee, Julian P. T. Higgins, et al.. (2008). Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus. Arthritis & Rheumatism. 58(7). 2098–2104. 30 indexed citations
12.
Sekine, Hideharu, Kareem L. Graham, Margaret K. Elliott, et al.. (2006). Role of MHC-Linked Genes in Autoantigen Selection and Renal Disease in a Murine Model of Systemic Lupus Erythematosus. The Journal of Immunology. 177(10). 7423–7434. 24 indexed citations
13.
Graham, Kareem L., Maria Vaysberg, Annie Kuo, & Paul J. Utz. (2006). Autoantigen arrays for multiplex analysis of antibody isotypes. PROTEOMICS. 6(21). 5720–5724. 20 indexed citations
14.
Graham, Kareem L., et al.. (2005). Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus. Arthritis & Rheumatism. 52(6). 1684–1693. 11 indexed citations
15.
Graham, Kareem L. & Paul J. Utz. (2005). Sources of autoantigens in systemic lupus erythematosus. Current Opinion in Rheumatology. 17(5). 513–517. 44 indexed citations
16.
Graham, Kareem L., William H. Robinson, Lawrence Steinman, & Paul J. Utz. (2004). High-throughput Methods for Measuring Autoantibodies in Systemic Lupus Erythematosus and other Autoimmune Diseases. Autoimmunity. 37(4). 269–272. 25 indexed citations
17.
Graham, Kareem L., Kurt E. Gustin, Sunny Choe, et al.. (2004). Proteolytic Cleavage of the Catalytic Subunit of DNA-Dependent Protein Kinase during Poliovirus Infection. Journal of Virology. 78(12). 6313–6321. 13 indexed citations
18.
Graham, Kareem L., James E. Fleming, Ry Young, & Klaus G. Bensch. (1989). Preparation of antibodies against xanthine oxidase from human milk. International Journal of Biochemistry. 21(7). 715–722. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026